DE3650368T2 - Use of Depogen to treat restricted blood circulation. - Google Patents
Use of Depogen to treat restricted blood circulation.Info
- Publication number
- DE3650368T2 DE3650368T2 DE3650368T DE3650368T DE3650368T2 DE 3650368 T2 DE3650368 T2 DE 3650368T2 DE 3650368 T DE3650368 T DE 3650368T DE 3650368 T DE3650368 T DE 3650368T DE 3650368 T2 DE3650368 T2 DE 3650368T2
- Authority
- DE
- Germany
- Prior art keywords
- depogen
- blood circulation
- diethoxy
- restricted blood
- treat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
The use of 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium-theophyl line-7-acetate (Depogen) for the manufacture of a medicament for use in the treatment of conditions resulting from restricted circulation of the blood in the smaller blood vessels by administration of an amount providing a drug blood concentration of 0.5 to 3 g<-><6>/ml calculated on the 1-(3',4'-diethoxy-benzyl)-6,7-diethoxy-3,4-dihydroisoquinoline.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU854639A HU197207B (en) | 1985-12-04 | 1985-12-04 | Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3650368D1 DE3650368D1 (en) | 1995-09-21 |
DE3650368T2 true DE3650368T2 (en) | 1996-01-18 |
Family
ID=10968537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3650368T Expired - Fee Related DE3650368T2 (en) | 1985-12-04 | 1986-12-04 | Use of Depogen to treat restricted blood circulation. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4814336A (en) |
EP (1) | EP0227356B1 (en) |
JP (1) | JPH0655672B2 (en) |
AT (1) | ATE126437T1 (en) |
DE (1) | DE3650368T2 (en) |
HU (1) | HU197207B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT60926A (en) * | 1991-04-12 | 1992-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability |
HUT68560A (en) * | 1993-08-02 | 1995-04-27 | Chinoin Gyogyszer Es Vegyeszet | The use of xantine derivatives for promotion of healing of operative lesions |
JP3276762B2 (en) * | 1993-12-28 | 2002-04-22 | 日本臓器製薬株式会社 | Pharmaceutical composition containing isoquinoline derivative |
AU2009319348B2 (en) * | 2008-11-27 | 2014-07-31 | Lidds Ab | Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics |
MX354485B (en) * | 2011-05-20 | 2018-03-07 | Chinoin Private Co Ltd | Pharmaceutical composition comprising drotaverine. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1129134A (en) * | 1964-11-04 | 1968-10-02 | Sterling Winthrop Group Ltd | Improvements in compositions containing nicotinates |
FR4135M (en) * | 1965-01-19 | 1966-05-02 | ||
DE1492203A1 (en) * | 1965-12-29 | 1970-01-15 | Thomae Gmbh Dr K | Process for the preparation of stable solutions of theophylline |
FR2181717B1 (en) * | 1968-11-25 | 1976-11-05 | Albert Ag Chem Werke | |
FR2202686A1 (en) * | 1972-10-13 | 1974-05-10 | Fabre Sa Pierre | Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia |
HU167246B (en) * | 1973-01-25 | 1975-09-27 | ||
FR2279394A2 (en) * | 1973-12-13 | 1976-02-20 | Saunier Laboratoires | Cerebral vasodilator compsns - of vincamine, ascorbic acid and papaverine hydrochloride for oral and parenteral admin |
US4364922A (en) * | 1980-10-14 | 1982-12-21 | University Of Virginia Alumni Patents Foundation | Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances |
US4383997A (en) * | 1980-11-26 | 1983-05-17 | Boucher John H | Method of treating horses to inhibit or reduce increases in crenated red blood cells during exercise |
-
1985
- 1985-12-04 HU HU854639A patent/HU197207B/en not_active IP Right Cessation
-
1986
- 1986-12-03 JP JP61288646A patent/JPH0655672B2/en not_active Expired - Lifetime
- 1986-12-03 US US06/937,536 patent/US4814336A/en not_active Expired - Fee Related
- 1986-12-04 DE DE3650368T patent/DE3650368T2/en not_active Expired - Fee Related
- 1986-12-04 AT AT86309456T patent/ATE126437T1/en not_active IP Right Cessation
- 1986-12-04 EP EP86309456A patent/EP0227356B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US4814336A (en) | 1989-03-21 |
ATE126437T1 (en) | 1995-09-15 |
EP0227356A2 (en) | 1987-07-01 |
HU197207B (en) | 1989-03-28 |
DE3650368D1 (en) | 1995-09-21 |
JPH0655672B2 (en) | 1994-07-27 |
EP0227356B1 (en) | 1995-08-16 |
HUT42940A (en) | 1987-09-28 |
EP0227356A3 (en) | 1989-12-13 |
JPS62187411A (en) | 1987-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3587941T2 (en) | DEVICE FOR PROVISIONAL REPERFUSION TREATMENT OF HEART ATTACK SYMPTOMS. | |
FI875533A0 (en) | INSULIN PREPARATIONS FOR NON-PARENTERAL DOSERING. | |
DE69230112D1 (en) | ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE | |
FI872756A (en) | MEDICAL REQUIREMENTS FOR THERAPEUTIC ANALYSIS. | |
DK0913156T3 (en) | Use of activated protein C for the treatment of hypercoagulation conditions associated with sepsis | |
ES2000428T3 (en) | PROCEDURE FOR PRODUCING A MEDICATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE, CONTAINING GALANTAMINE, AND CORRESPONDING MEDICAL DEVICE. | |
SE9401406L (en) | Pharmaceutical products for the cure of tumor diseases as well as a method for the preparation thereof | |
DE3680368D1 (en) | BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIE FACTOR, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS. | |
DE3582439D1 (en) | MEDICINE FOR TREATING HEART DISEASES. | |
ATA91797A (en) | A PHARMACEUTICAL PREPARATION CONTAINING THE VWF PROPEPTIDE | |
DE68929388T2 (en) | Anticoagulant compound isolated from urine | |
DK47089D0 (en) | SUBSTANCE WITH DAMAGING EFFECT ON TIMAL TUMORS, PROCEDURES FOR THE PREPARATION OF SUCH AGENTS AND THE USE OF THESE FOR THERAPEUTIC TREATMENT OF CANCER | |
DE3685853T2 (en) | AGENTS FOR THE TREATMENT OF BONE DISEASES. | |
ATE80039T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING 2',3'-DIDEOXYCYTIDIN-2'-EN(2',3'-DIDEOXY-2',3'DIDEHYDROCYTIDIN) FOR THE TREATMENT OF PATIENTS INFECTED WITH RETROVIRUS. | |
DE3650368T2 (en) | Use of Depogen to treat restricted blood circulation. | |
KR890000108A (en) | Pharmaceutical composition for the treatment of tumor | |
ATE25969T1 (en) | 1,7-DIPHENYL-3-METHYLAZA-7-CYAN-8-METHYL-NONANE FOR USE IN COMBATING DISEASE. | |
DE3380923D1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS. | |
DE3687233T2 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATING SKIN DISEASES. | |
DE3876425D1 (en) | CONTROLLED ADMINISTRATION OF BLOOD. | |
DK0499679T3 (en) | Therapeutic agent for diabetic gangrene | |
DE3280419T2 (en) | MEDICAL PREPARATION FOR TREATING SKIN DISEASES. | |
DE3772047D1 (en) | PYRAZIN FOR TREATING HAEMODYNAMIC AND METABOLIC DISEASES. | |
RO94684A2 (en) | TREATMENT MEDICINE FOR DERMATOSES | |
IT8148480A0 (en) | THERAPEUTIC COMPOSITION AND SYSTEM FOR THE EXTRACORPOREAL TREATMENT OF WHOLE BLOOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |